Owner: Sodany Ly • Company: Withings • Contact: [email protected]

Making a complex innovation land with press and consumers

<aside> <img src="/icons/paste_gray.svg" alt="/icons/paste_gray.svg" width="40px" />

Case study at a glance

Challenge: Launch Withings' most scientifically ambitious product to date (EDA/Nerve assessment and 6-lead ECG) before FDA clearance, at CES, with a lean hybrid team.

Approach: As Interim CMO, owned marketing end-to-end: negotiated claims between Regulatory, Product and the CEO, led messaging and asset production, validated commercial roll-out.

Outcome: The launch beat its PR and waitlist targets, marking the strongest CES result in Withings' history (+100K waitlist subscriptions from new + existing customers), achieved with a smaller team than prior launches.

</aside>

The challenge

Body Scan was Withings' most advanced smartscale, built on EDA and Nerve assessment technology and a 6-lead ECG — none of it yet FDA-approved at the moment we needed to announce it at CES. The job was to make the innovation land with press and consumers without overstepping what Regulatory would clear, and to pull off the announcement with a reduced footprint: a small US team on-site, the CEO's reveal delivered remotely.

What I did

1. Messaging strategy under regulatory constraint

2. Coordinating the announcement, remotely and on a deadline

3. Commercial roll-out

Deliverables

image.png

image.png

The outcome

<aside> ✦

The launch beat its PR and waitlist targets, marking the strongest CES result in Withings' history, achieved with a smaller on-site team than prior launches.

</aside>

Ways of working